Company: INTS
Filing Date: 2025-09-09
Form Type: DEF 14A
Source: 0001567264-25-000090
Chunk: 2

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-09-09
Form: DEF 14A
Chunk 2
---
 fully described in the proxy statement accompanying this notice.

The record date for the Special Meeting is Friday, August 29, 2025. Only stockholders of record at the close of business on that date may vote at the meeting or any adjournment or postponement thereof.

All stockholders are cordially invited to attend the Special Meeting. Whether you plan to attend the Special Meeting or not, we urge you to vote and submit your proxy by the internet, telephone, or mail in order to ensure the presence of a quorum.

It is important that your shares be represented and voted whether or not you plan to attend the Special Meeting virtually. You may vote on the internet, by telephone, or by completing and mailing a proxy card or voting instruction form. Submitting your proxy over the internet, by telephone, or by mail will ensure your shares are represented at the Special Meeting. You may change or revoke your proxy at any time before it is voted at the Special Meeting. Please read the enclosed information carefully before voting.

Your vote is important. Even if you plan to attend the Special Meeting, we urge you to submit your proxy or voting instructions as soon as possible.

BY ORDER OF THE BOARD OF DIRECTORS

#### Lewis H. Bender

#### President, Chief Executive Officer and Chairman

#### September 9, 2025

### IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS

### FOR THE SPECIAL MEETING OF STOCKHOLDERS

#### TO BE HELD ON OCTOBER 22, 2025
This Proxy Statement, the Notice of Special Meeting of Stockholders and our form of proxy card are available for viewing at www.proxyvote.com. To view these materials please have your 16-digit control numbers available that appears on your proxy card.

Additionally, you can find a copy of our Annual Report on Form 10-K, which includes our financial statements for the fiscal year ended December 31, 2024, on the website of the Securities and Exchange Commission, or the SEC, at www.sec.gov, or in the “SEC Filings” section of the “Investors” section of our website at ir.intensitytherapeutics.com/sec-filings. You may also obtain a printed copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, including our financial statements, free of charge, from us by sending a written request to:

#### Joseph Talamo

#### Intensity Therapeutics, Inc.

#### 1 Enterprise Drive,